TP53 mutation predicts the poor prognosis of non-Hodgkin lymphomas: Evidence from a meta-analysis

Non-Hodgkin lymphoma (NHL) is a group of malignant hematologic disorders with high heterogeneity. The diagnosis, clinical manifestations, classification, and prognosis of this condition differ among numerous NHL subgroups. The prognostic significance of the mutation of TP53, a tumor suppressor gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Peipei, Liu, Xu, Ouyang, Jian, Chen, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378372/
https://www.ncbi.nlm.nih.gov/pubmed/28369138
http://dx.doi.org/10.1371/journal.pone.0174809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378372/
https://www.ncbi.nlm.nih.gov/pubmed/28369138
http://dx.doi.org/10.1371/journal.pone.0174809

Ejemplares similares